Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GAIA-123
- Development stage
- Preclinical
- Lead developer
- GAIA BioMedicine
- Modality
- CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
01
Overview
GAIA-123 is a preclinical-stage, antibody-armed NK-like cell therapy being developed by GAIA BioMedicine Inc. for the treatment of undisclosed solid tumors expressing a specific target, referred to as Target C. The therapy utilizes GAIA's proprietary NK-like cells, which are armed with a specific antibody to enhance tumor targeting and direct NK-mediated cytotoxicity against tumor-associated antigens. This approach aims to combine the potent innate killing capacity of NK-like cells with the high specificity of monoclonal antibodies to effectively target and eliminate cancer cells while potentially overcoming the immunosuppressive tumor microenvironment.
- Other names
- GAIA-123 (antibody-armed)
Beyond the preview
Go deeper on GAIA-123.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GAIA-123.